Publication & Citation Trends
Most Cited Works
Publications
153 total
Abstract 4038: Anti-ROR2 therapies target cancer stem cells in triple-negative breast cancer
Cited by 0
Semantic Scholar
Dual targeting of ROR1 and ROR2 with glycoengineered antibodies elicits potent and selective immunotherapy in hairy cell leukemia
Cited by 0
Semantic Scholar
Abstract 7176: ROR1-dependent mutant TP53 and cyclin A1 increases, via NRF2 activation, potentially potentiate genomic instability in chronic lymphocytic leukemia cells with del(17p)
Cited by 0
Semantic Scholar
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer OA
Cited by 12
Semantic Scholar
Variant Transcript of ROR1 ENST00000545203 Does Not Encode ROR1 Protein OA
Cited by 1
Semantic Scholar
Defining Signaling Interactomes Involved in Non-Canonical Wnt Signaling By ROR1 or ROR2 in Hairy Cell Leukemia That Can Influence Cell Morphology and Migration OA
Cited by 0
Semantic Scholar
High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia OA
Cited by 21
Semantic Scholar
Abstract LB255: Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer OA
Cited by 0
Semantic Scholar
Research Topics
Chronic Lymphocytic Leukemia Research
(62)
Monoclonal and Polyclonal Antibodies Research
(27)
Galectins and Cancer Biology
(25)
Wnt/β-catenin signaling in development and cancer
(18)
Immunodeficiency and Autoimmune Disorders
(18)
Frequent Co-Authors
Affiliations
La Jolla Institute for Immunology
University of California, Los Angeles
The Aerospace Corporation
Shenzhen University
Long Island Jewish Medical Center